agn-199201
Small moleculeexperimental
Clinical trial activity
6 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
5
Phase 3
1
Phase 4
0
Earliest trial started Apr 1, 2012 (NCT01579084)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- agn-199201
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02780115 | Phase 2 | May 1, 2016 | Allergan |
| NCT02595528 | Phase 2 | Apr 29, 2016 | Allergan |
| NCT02197806 | Phase 2 | Jul 1, 2014 | Allergan |
| NCT02131636 | Phase 3 | May 1, 2014 | Allergan |
| NCT01735201 | Phase 2 | Dec 1, 2012 | Allergan |
| NCT01579084 | Phase 1 | Apr 1, 2012 | Allergan |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Allergan | For profit | 6 | 6 | 3 | 2012 |
1 organizations
Page 1 / 1